Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Companies
Companies
Hospira
Hospira
Company Information
Key Financials (last Fiscal Year)
Profit Ratios
Earnings Per Share (last Fiscal Year)
Total Return
Company Information
Company Information
Key Financials (last Fiscal Year)
Profit Ratios
Earnings Per Share (last Fiscal Year)
Total Return
Updated:
Country/Territory:
Headquarters:
Lake Forest, IL
Industry:
Pharmaceuticals
CEO:
F. Michael Ball
Website:
https://www.hospira.com
Ticker:
Company type:
Revenues ($M):
$4,464
Profits ($M):
$333
Market value ($M):
$15,142
Number of employees:
19,000
$ millions
% change
Revenues ($M):
$4,464
11.5%
Profits ($M):
$333
-
Total Stockholder Equity ($M):
$3,337
-
Employees:
19,000
-
Market Value ($M):
$15,142
-
Profit as % of Revenues:
7.5%
Profits as % of Assets:
5%
Profits as % of Stockholder Equity:
10%
Earnings Per Share ($):
1.95
EPS % Change (5 year annual rate):
-4.6%
EPS % Change (10 year annual rate):
0.2%
Total Return to Investors (last year):
48.4%
Total Return to Investors (5 year, annualized):
3.7%
Total Return to Investors (10 year, annualized):
6.2%
Hospira in Fortune Rankings
Fortune 500
Fortune 500
Fortune 500
2015
2015
2014
2014
2013
2013
2012
2012
2011
2011
2010
2010
2009
2009
2008
2008
2007
2007
2006
2006
View the Full List